FDA Approves Sorilux for Adolescent Plaque Psoriasis
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
Medical-grade skincare is more than an add-on—it’s essential for optimizing aesthetic treatments, reducing downtime, and keeping patients engaged. By integrating pre- and post-procedure skincare, providers can improve results, increase patient retention, and drive revenue growth. Discover how medical-grade skincare creates a sustainable business model and enhances long-term success in aesthetic medicine.